Cardiovascular Surgical Procedure
Conditions
Keywords
Inhaled anesthesia, Total intravenous anesthesia
Brief summary
This study compares the difference in proinflammatory markers Interleukin 6 (IL-6), Tumor necrosis factor alpha (TNFα) and cortisol in patients undergoing cardiovascular surgery to asses if there is a benefit of using intravenous total anesthesia (TIVA) over inhaled anesthesia for this procedures.
Detailed description
IL-6, TNFα and cortisol will be measure at the beginning of the cardiovascular surgery and 20 minutes after the cardiovascular bypass ends to calculate the difference between them and compare if there is any statistical difference between the proinflammatory markers with the two anesthesia techniques.
Interventions
Propofol anesthesia Dose: 4-6mg/kg/h
Inhaled anesthesia with sevoflurane. Dose: 1-2.5 Minimum Alveolar Concentration(MAC)
Sponsors
Study design
Eligibility
Inclusion criteria
Scheduled for cardiovascular surgery American Society of Anaesthesiologists (ASA) physical status classification II-IV BMI \< 25 HbA1c \< 7%
Exclusion criteria
Diabetic patients Known allergy to propofol
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| IL-6 | The difference between IL-6 at the begging of surgery and 20 minutes after the end of the cardiopulmonary bypass | IL-6 will be compared between the groups. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| TNFα | The difference between TNFα at the begging of surgery and 20 minutes after the end of the cardiopulmonary bypass | TNFα will be compared between the groups |
| Cortisol | The difference between cortisol at the begging of surgery and 20 minutes after the end of the cardiopulmonary bypass | Cortisol will be compared between the groups |
Countries
Mexico